Indications and uses
Controls the symptoms of diarrhea, including Travelers diarrhea.
Controls the symptoms of diarrhea, including Travelers diarrhea.
do not use more than directed drink plenty of clear fluids to help prevent dehydration caused by diarrhea Adults and children (12 years and older): Take 2 caplets after the first loose stool followed by 1 caplet after each subsequent loose stool but no more than 4 caplets in 24 hours. Children under 12 years: Do not give to children under 12 years of age.
Drug Facts
Loperamide Hydrochloride 2mg
Antidiarrheal
Controls the symptoms of diarrhea, including Travelers diarrhea.
Allergy alert: Do not use if you have ever had a rash or other allergic reaction to Loperamide HCl
If you are pregnant or breast feeding, ask a health professional before use.
Keep this and all drugs out of the reach of children. In case of accidental overdose, contact a physician or Poison Control Center right away.
Adults and children (12 years and older): Take 2 caplets after the first loose stool followed by 1 caplet after each subsequent loose stool but no more than 4 caplets in 24 hours.
Children under 12 years: Do not give to children under 12 years of age.
anhydrous lactose, croscarmellose sodium, crospovidone, D&C Yellow # 10, FD&C Blue # 1, hydrogenated vegetable oil, magnesium stearate, powdered cellulose, pregelatinized starch
Medique ®
Diamode
Controls the Symptoms of Diarrhea
Pull to Open
THIS PACKAGE IS FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
✓Anti-diarrheal • Loperamide HCl 2 mg
24 Caplets
(24 x 1)
Tamper Evident Unit Dose Packets
Physicians Care®
Anti-Diarrheal
Controls Symptoms of Diarrhea
Loperamide Hydrochloride 2 mg
Pull To Open
Easy to Swallow
COATED CAPLETS
Compare Active ingredient to:
Imodium AD
Registered Trademark of McNeil Consumer & Specialty Pharmaceuticals
Tamper-Evident Unit Dose Packets
Physicians Care®
Registered Trademark of ACME UNITED Corporation
50 PACKETS (1 Caplet 2 Mg Each)
Compare to the Active Ingredients in
Imodium® A-D
This box contains a generic product called Diamode
Anti-Diarrheal Relief
20 Packets of 2 Tablets
Remove This Panel
Read Drug Facts and Instructions on Packet
| Class | Version | Type | Effective |
|---|---|---|---|
| LOPERAMIDE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0347682200640 | GTIN-13: 0347682200640 EAN-13: 0347682200640 GTIN-12: 347682200640 UPC-A: 347682200640 GTIN storage (14 digits): 00347682200640 | 200R Diamode 20064 Gran 3-5-25.jpg, 200R Diamode 20064 OHM 3-5-25.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 10f838ef-a72b-645d-80f8-e2255205c3b1 | Product name | 6 | 20240805 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47682-021-25 | Private Label Distributor | 25 in 1 BOX, UNIT-DOSE | TABLET | 25 | 22 | |
| 47682-021-25 | Private Label Distributor | 1 in 1 PACKET | TABLET | 1 | 22 | |
| 47682-021-30 | Private Label Distributor | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 22 | |
| 47682-021-30 | Private Label Distributor | 1 in 1 PACKET | TABLET | 1 | 22 | |
| 47682-021-50 | Private Label Distributor | 50 in 1 BOX, UNIT-DOSE | TABLET | 50 | 22 | |
| 47682-021-50 | Private Label Distributor | 1 in 1 PACKET | TABLET | 1 | 22 | |
| 47682-021-75 | Private Label Distributor | 1 in 1 PACKET | TABLET | 1 | 22 | |
| 47682-021-75 | Private Label Distributor | 75 in 1 BOX, UNIT-DOSE | TABLET | 75 | 22 | |
| 47682-200-33 | MEDIQUE Diamode | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 22 | |
| 47682-200-46 | MEDIQUE Diamode | 1 in 1 PACKET | TABLET | 1 | 22 | |
| 47682-200-50 | MEDIQUE Diamode | 1 in 1 PACKET | TABLET | 1 | 22 | |
| 47682-200-50 | MEDIQUE Diamode | 50 in 1 BOX, UNIT-DOSE | TABLET | 50 | 22 | |
| 47682-200-64 | MEDIQUE Diamode | 24 in 1 BOX, UNIT-DOSE | TABLET | 24 | 22 | |
| 47682-200-69 | MEDIQUE Diamode | 1 in 1 PACKET | TABLET | 1 | 22 | |
| 47682-200-69 | MEDIQUE Diamode | 6 in 1 BOX, UNIT-DOSE | TABLET | 6 | 22 | |
| 47682-400-46 | MEDIQUE Diamode | 1 in 1 PACKET | TABLET | 1 | 22 | |
| 47682-400-64 | MEDIQUE Diamode | 24 in 1 BOX, UNIT-DOSE | TABLET | 24 | 22 | |
| 47682-400-69 | MEDIQUE Diamode | 6 in 1 BOX, UNIT-DOSE | TABLET | 6 | 22 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 47682-200-33 | EA - Each | 47682-200 | f07bc0d3-2ced-4052-ba14-126376ba97df | 1 | 2012-07-24 |
| 47682-200-50 | EA - Each | 47682-200 | 1792fba4-32e7-461b-9844-385042675db5 | 1 | 2012-07-24 |
| 47682-200-64 | EA - Each | 47682-200 | 94aca123-bb93-43e6-bf00-3c3df07db82a | 1 | 2023-08-08 |
| 47682-200-69 | EA - Each | 47682-200 | 80247ac0-4431-4ac1-893d-7b7a9a0347e9 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LOPERAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | 77TI35393C | 5 | |
| LOPERAMIDE | ACTIVE MOIETY | 6X9OC3H4II | 5 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | 5 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 5 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | 5 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | 5 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 5 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | 5 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 47682-021 | 47682-021-50, 47682-021-25, 47682-021-30, 47682-021-75 |
| 47682-200 | 47682-200-69, 47682-200-50, 47682-200-46, 47682-200-33, 47682-200-64 |
| 47682-400 | 47682-400-46, 47682-400-69, 47682-400-64 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074091-001 | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Private Label Distributor | LOPERAMIDE HCL 2 MG | Unifirst First Aid Corporation | 069e7979-a223-4819-b6cf-ea2731bf156b | 2025-12-01 | Warnings | 47682-200-69 47682-200-46 47682-200-33 47682-400-46 47682-400-69 47682-021-30 47682-400-64 47682-200-64 47682-021-25 47682-021-75 47682-200-50 47682-021-50 47682-021 47682-200 47682-400 47682020069 47682020046 47682002150 47682002130 47682040064 47682002175 47682040046 47682002125 47682020033 47682020050 47682020064 47682040069 441e7620-28e5-8cc5-e063-6394a90a2a72 069e7979-a223-4819-b6cf-ea2731bf156b |
Adverse event summaries are temporarily unavailable. Other product information remains available.